Data gathered: May 16
AI Stock Analysis - Tempus AI (TEM)
Analysis generated March 18, 2025. Powered by Chat GPT.
Tempus AI is a leading player in the artificial intelligence sector, specializing in healthcare and precision medicine. Utilizing advanced machine learning and data analytics, Tempus AI aims to revolutionize how medical professionals diagnose and treat diseases. The company’s technology platform integrates clinical and molecular data, providing actionable insights for healthcare providers. With a focus on improving patient outcomes, Tempus AI has been gaining traction in the medical community and has shown consistent growth in terms of revenue and market presence.
Stock Alerts - Tempus AI (TEM)
 |
Tempus AI | May 14 Insider Alert: Leonsis Theodore is selling shares |
|
Tempus AI | May 13 Price is up by 12.3% in the last 24h. |
|
Tempus AI | May 9 Insider Alert: Fukushima Ryan is selling shares |
|
Tempus AI | May 8 Price is up by 8.2% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Tempus AI
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 147 | Sign up | Sign up | Sign up |
| Sentiment | 93 | Sign up | Sign up | Sign up |
| Webpage traffic | 134,000 | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | 22 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Instagram Followers | 2,603 | Sign up | Sign up | Sign up |
| Reddit Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 501 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 14,794 | Sign up | Sign up | Sign up |
| Twitter Followers | 10,263 | Sign up | Sign up | Sign up |
| Twitter Mentions | 1,432 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 2,350 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 47 | Sign up | Sign up | Sign up |
| Linkedin Employees | 2,706 | Sign up | Sign up | Sign up |
About Tempus AI
Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties.
| Price | $62.60 |
| Target Price | Sign up |
| Volume | 11,140,000 |
| Market Cap | $11.2B |
| Year Range | $31.83 - $89.44 |
| Dividend Yield | 0% |
| Analyst Rating | 57% buy |
| Industry | Health Care Services |
In the news
 |
Boehringer partners Tempus AI to enhance cancer therapy pipelineMay 15 - Pharmaceutical Technology |
Why Tempus AI Inc. (TEM) Skyrocketed On TuesdayMay 13 - Yahoo Entertainment |
|
 |
Tempus AI announces six posters accepted for presentation at ISPOR 2025May 13 - Thefly.com |
Is Tempus AI, Inc. (TEM) the Best Performing Healthcare Stock to Buy Now?May 13 - Yahoo Entertainment |
|
 |
Investors Purchase Large Volume of Tempus AI Call Options (NASDAQ:TEM)May 8 - ETF Daily News |
|
Tempus AI, Inc. (NASDAQ:TEM) Shares Acquired by Stifel Financial CorpMay 8 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 256M | 101M | 155M | -68M | 0 | -0.240 |
| Q4 '24 | 201M | 79M | 122M | -13M | 12M | -0.180 |
| Q3 '24 | 181M | 78M | 103M | -76M | -51M | -0.250 |
| Q2 '24 | 166M | 94M | 72M | -552M | -530M | -0.630 |
| Q1 '24 | 146M | 71M | 75M | -65M | -42M |
Insider Transactions View All
| Leonsis Theodore filed to sell 43,550 shares at $66.3. May 13 '25 |
| Fukushima Ryan filed to sell 884,460 shares at $53.4. May 8 '25 |
| Fukushima Ryan filed to sell 897,240 shares at $51.9. May 8 '25 |
| Fukushima Ryan filed to sell 885,050 shares at $52.6. May 8 '25 |
| Epstein David R filed to sell 25,914 shares at $53.5. May 5 '25 |
Similar companies
Read more about Tempus AI (TEM) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Tempus AI?
The Market Cap of Tempus AI is $11.2B.
What is the current stock price of Tempus AI?
Currently, the price of one share of Tempus AI stock is $62.60.
How can I analyze the TEM stock price chart for investment decisions?
The TEM stock price chart above provides a comprehensive visual representation of Tempus AI's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Tempus AI shares. Our platform offers an up-to-date TEM stock price chart, along with technical data analysis and alternative data insights.
Does TEM offer dividends to its shareholders?
As of our latest update, Tempus AI (TEM) does not offer dividends to its shareholders. Investors interested in Tempus AI should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Tempus AI?
Some of the similar stocks of Tempus AI are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.